Publications and Digital Products

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

This Joint SAMHSA-CMS informational Bulletin provides guidance to states and school systems about addressing mental health and substance use issues in schools. It provides examples of approaches for services in schools and describes some Medicaid authorities that states may use to cover services.

This report highlights programs that promote recovery and build resilience among older adolescents and young adults living with serious mental illness. It describes initiatives that address employment, housing, education, social connectedness, and emotional well-being.

This kit provides tools to assist in developing mental health programs that help prevent or reduce severe aggressive behavioral, emotional, and development issues in children by enhancing the knowledge of parents, caregivers, and providers. It includes six booklets.